Molecular epidemiology of tuberculosis in foreign-born persons living in San Francisco

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 9, 2013, Pages 998-1006

  Suwanpimolkul, Gompol ^a,b   Jarlsberg, Leah G ^a   Grinsdale, Jennifer A ^c   Osmond, Dennis ^a   Masae Kawamura, L ^c   Hopewell, Philip C ^a   Kato Maeda, Midori ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Epidemiology; Foreign born populations; Mycobacterium tuberculosis; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; AGED; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHINA; CLINICAL FEATURE; DISEASE COURSE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GENOTYPE; GEOGRAPHIC ORIGIN; HUMAN; INCIDENCE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEXICO; MICROBIOLOGICAL EXAMINATION; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHILIPPINES; PHYLOGEOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED STATES;

CHINA; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; INCIDENCE; MALE; MEXICO; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PHILIPPINES; PHYLOGEOGRAPHY; PROSPECTIVE STUDIES; RISK FACTORS; SAN FRANCISCO; SYMPATRY; TUBERCULOSIS;

EID: 84877109506     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201212-2239OC     Document Type: Article

References (42)

1. Centers of Disease Control and Prevention. Trends in tuberculosis - United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:181-185.
2. Cattamanchi A, Hopewell PC, Gonzalez L.C., Osmond DH, Masae Kawamura L, Daley CL, Jasmer RM A 13-year molecular epidemiological analysis of tuberculosis in San Francisco. Int J Tuberc Lung Dis 2006; 10: 297-304.
3. Chin DP, DeRiemer K, Small P.M., de Leon AP, Steinhart R, Schecter GF, Daley CL, Moss A.R., Paz EA, Jasmer RM, et al. Differences in contributing factors to tuberculosis incidence in US-born and foreign-born persons. Am J Respir Crit Care Med 1998; 158:1797-1803.
4. Jasmer RM, Hahn JA, Small P.M., Daley CL, Behr MA, Moss AR, Creasman JM, Schecter G.F., Paz EA, Hopewell PC. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med 1999; 130:971-978.
5. El Sahly H.M., Adams GJ, Soini H, Teeter L., Musser JM, Graviss EA Epidemiologic differences between United States- and foreign-born tuberculosis patients in Houston, Texas. J Infect Dis 2001; 183:461-468.
6. Geng E, Kreiswirth B, Driver C., Li J, Burzynski J, DellaLatta P., LaPaz A, Schluger NW. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med 2002; 346:1453-1458.
7. World Health Organization. Global tuberculosis control. Report No. WHO/HTM/TB/2012.6. Geneva, Switzerland: World Health Organization; 2012.
8. Centers of Disease Control and Prevention. Technical instructions for tuberculosis screening and treatment. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2009 [accessed 2012 Aug 12]. Available from: http://www.cdc.gov/immigrantrefugeehealth/pdf/ tuberculosis-ti-2009.pdf
9. CDC's Division of Global Migration and Quarantine. Notice to readers: revised technical instructions for tuberculosis screening and treatment for panel physicians. MMWR Morb Mortal Wkly Rep 2008; 57:292-293.
10. Qu HQ, Fisher-Hoch SP, McCormick JB Knowledge gaining by human genetic studies on tuberculosis susceptibility. J Hum Genet 2011; 56: 177-182.
11. de Jong B.C., Hill PC, Aiken A, Awine T., Antonio M, Adetifa IM, Jackson-Sillah DJ, Fox A., Deriemer K, Gagneux S, et al. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in the Gambia. J Infect Dis 2008; 198:1037-1043.
12. Gagneux S, DeRiemer K, Van T., Kato-Maeda M, de Jong BC, Narayanan S, Nicol M, Niemann S, Kremer K, Gutierrez MC, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2006; 103:2869-2873.
13. Kato-Maeda M., Shanley CA, Ackart D, Jarlsberg L.G., Shang S., Obregon-Henao A, Harton M, Basaraba R.J., Henao-Tamayo M, Barrozo JC, et al. Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig. Clin Vaccine Immunol 2012; 19:1227-1237.
14. Suwanpimolkul G, Jarlsberg L, Osmond D., Grinsdale J, Kawamura M, Hopewell P.C., Kato-Maeda M. Molecular epidemiology of tuberculosis in foreign-born persons in San Francisco [abstract]. Am J Respir Crit Care Med 2012; 185:A3250.
15. U.S. Census Bureau. San Francisco California Population and Demographics Resources. 2000 [accessed on 2012 Jun 15]. Available from: http://sanfrancisco. areaconnect.com/statistics.htm
16. US Census Bureau. State & County QuickFacts. San Francisco County, California. 2010 [accessed 2012 Jul 5]. Available from: http://quickfacts. census.gov/qfd/states/06/06075.html
17. Grantmakers Concerned with Immigrants and Refugees. San Francisco, California [accessed 2012 May 10]. Available from: http://www.gcir.org/node/ 2873.
18. van Embden J.D., Cave MD, Crawford J.T., Dale JW, Eisenach KD, Gicquel B, Hermans P., Martin C, McAdam R, Shinnick TM, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31:406-409.
19. Rhee JT, Tanaka MM, Behr M.A., Agasino CB, Paz EA, Hopewell PC, Small PM Use of multiple markers in population-based molecular epidemiologic studies of tuberculosis. Int J Tuberc Lung Dis 2000; 4: 1111-1119.
20. Cain KP, Haley CA, Armstrong L.R., Garman KN, Wells CD, Iademarco MF, Castro KG, Laserson KF Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination. Am J Respir Crit Care Med 2007; 175:75-79.
21. Cain KP, Benoit SR, Winston C.A., Mac Kenzie WR. Tuberculosis among foreign-born persons in the United States. JAMA 2008; 300: 405-412.
22. Linas BP, Wong AY, Freedberg K.A., Horsburgh CR Jr. Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med 2011; 184:590-601.
23. World Health Organization. Global tuberculosis control. Geneva, Switzerland: World Health Organization; 2003. Report No. WHO/CDS/TB/2003.316.
24. World Health Organization. Global tuberculosis control. Geneva, Switzerland: World Health Organization; 2011. Report No. WHO/HTM/TB/2011.16.
25. World Health Organization. Global tuberculosis control. Geneva, Switzerland: World Health Organization; 2010. Report No. WHO/HTM/TB/2010.7.
26. Trading Economics. Incidence of tuberculosis (per 100, 000 people) in Mexico. 2010. Available from: http://www.tradingeconomics.com/mexico/incidence- of-tuberculosis-per-100,000-people-wb-data.html
27. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000; 49:1-51.
28. Wells CD, Ocana M, Moser K., Bergmire-Sweat D, Mohle-Boetani JC, Binkin NJ. A study of tuberculosis among foreign-born hispanic persons in the US States bordering Mexico. Am J Respir Crit Care Med 1999; 159:834-837.
29. Lurie N, Dubowitz T. Health disparities and access to health. JAMA 2007; 297:1118-1121.
30. Dennis AM, Napravnik S, Sena A.C., Eron JJ Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort. Clin Infect Dis 2011; 53:480-487.
31. Li X, Xu P, Shen X., Qi L, DeRiemer K, Mei J., Gao Q. Non-Beijing strains of Mycobacterium tuberculosis in China. J Clin Microbiol 2011; 49:392-395.
32. Pang Y, Zhou Y, Zhao B., Liu G, Jiang G, Xia H., Song Y, Shang Y, Wang S, Zhao YL. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One 2012; 7:e32976.
33. Stead WW. The pathogenesis of pulmonary tuberculosis among older persons. Am Rev Respir Dis 1965; 91:811-822.
34. Gagneux S, Burgos MV, DeRiemer K, Encisco A., Munoz S, Hopewell PC, Small PM, Pym AS Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog 2006; 2:e61.
35. Metcalfe JZ, Kim EY, Lin S.Y., Cattamanchi A., Oh P, Flood J, Hopewell P.C., Kato-Maeda M. Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007. Emerg Infect Dis 2010; 16:1403-1409.
36. van Doorn H.R., de Haas PE, Kremer K, Vandenbroucke-Grauls CM, Borgdorff MW, van Soolingen D. Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of kat G: a decade of experience in the Netherlands. Clin Microbiol Infect 2006; 12:769-775.
37. Hu Y, Hoffner S, Jiang W., Wang W, Xu B. Extensive transmission of isoniazid resistant M. BMC Infect Dis 2010; 10:43.
38. Martinson NA, Barnes GL, Moulton L.H., Msandiwa R., Hausler H, Ram M, McIntyre J.A., Gray GE, Chaisson RE. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med 2011; 365: 11-20.
39. Reed MB, Gagneux S, Deriemer K., Small PM, Barry CE III. The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol 2007; 189:2583-2589.
40. Thwaites G, Caws M, Chau T.T., D'Sa A, Lan NT, Huyen MN, Gagneux S, Anh P.T., Tho DQ, Torok E, et al. Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J Clin Microbiol 2008; 46: 1363-1368.
41. Click ES, Moonan PK, Winston C.A., Cowan LS, Oeltmann JE Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. Clin Infect Dis 2012; 54:211-219.
42. Reed MB, Domenech P, Manca C., Su H, Barczak AK, Kreiswirth BN, Kaplan G, Barry CE III. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004; 431: 84-87.